Printer Friendly

BIO/DYNAMICS SUBSIDIARY OF APPLIED BIOSCIENCE INTERNATIONAL TO BEGIN TESTING ON AIDS PRODUCT FOR FUTURE MEDICAL PRODUCTS, INC.

 BIO/DYNAMICS SUBSIDIARY OF APPLIED BIOSCIENCE INTERNATIONAL TO BEGIN TESTING ON AIDS PRODUCT FOR FUTURE MEDICAL PRODUCTS, INC.
 EAST MILLSTONE, N.J., March 31 /PRNewswire/ -- Dr. Geoffrey Hogan president of the Bio/dynamics subsidiary of Applied Bioscience International Inc. (NASDAQ: APBI), announced today that the company had signed a contractual agreement with Future Medical Products, Inc. of Hauppauge, N.Y., to commence testing necessary to meet U.S. Food and Drug Administration requirements for commercializing products using Future Medical's patented procedure utilizing an organic compound for the neutralization of AIDS.
 Hogan stated that Bio/dynamics was pleased to be working with the researchers at Albert Einstein College of Medicine who developed the compound, and Future Medical Products to help further the fight against AIDS.
 Applied Bioscience International Inc. provides a broad range of inter-related services, which include biological safety testing, clinical research and development, agrochemical research and development and the assessment and management of environmental risk. The company provides such services under contract to clients in the pharmaceutical, general chemical, agrochemical, nutritional and other industries throughout the world.
 -0- 3/31/92
 /CONTACT: Dr. Geoffrey Hogan, president of Bio/dynamics, 908-873-2550, or John McNamara of John McNamara Advertising, 212-509-7779, for Bio/dynamics/
 (APBI) CO: Applied Bioscience International Inc. ST: New Jersey IN: MTC SU: PDT


CK-SM -- NY034 -- 3315 03/31/92 10:17 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 31, 1992
Words:224
Previous Article:PAULSON CAPITAL REPORTS RECORD REVENUES AND EARNINGS FOR FISCAL 1991
Next Article:USLIFE CORPORATION ANNOUNCES REDEMPTION OF 7.75 PERCENT NOTES
Topics:


Related Articles
APPLIED BIOSCIENCE INTERNATIONAL MERGES WITH PHARMACO DYNAMICS RESEARCH
APPLIED BIOSCIENCE INTERNATIONAL REPORTS FIRST FINANCIAL RESULTS SINCE RECENT MERGER WITH PHARMACO
CEL-SCI CORPORATION NAMES TWO OUTSIDERS TO ITS BOARD OF DIRECTORS
ENVIRONMENTAL TESTING AND CERTIFICATION CORP., A WHOLLY-OWNED SUBSIDIARY OF APPLIED BIOSCIENCE, PURCHASES STAKE IN ENSYS ENVIRONMENTAL PRODUCTS
APPLIED BIOSCIENCE INTERNATIONAL INC. UNITES ITS THREE MAJOR LIFE SCIENCE COMPANIES TO FORM PHARMACO-LSR AND APPOINTS DEFESCHE PRESIDENT
DISEASE DETECTION INTERNATIONAL, INC., SIGNS EXCLUSIVE DISTRIBUTION AGREEMENT FOR SEVEN-MINUTE AIDS TEST FOR ARGENTINA
Cryo-Cell signs exclusive world-wide licensing and research agreement with University of South Florida.
BIO and Battelle to Present Comprehensive Bioscience Industry Study at BIO 2006 Annual International Convention.
Bioscience Industry Fuels Jobs and Growth for States, Industry Study Finds.
Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters